2015 - Fellow of the Royal Society, United Kingdom
1995 - Fellow of the Royal Society of Edinburgh
Allan Balmain mainly focuses on Carcinogenesis, Cancer research, Immunology, Gene and Tumor suppressor gene. Allan Balmain combines subjects such as Cell, Mutation, Tumor progression, Transforming growth factor beta and In vivo with his study of Carcinogenesis. His Cancer research research integrates issues from Epithelium and Cancer.
His Immunology study combines topics in areas such as Malignant transformation, Malignancy, Skin cancer and Malignant Conversion. His studies in Gene integrate themes in fields like Papilloma and DNA. His research integrates issues of Transgene, TOR Serine-Threonine Kinases, Allele and Pathology in his study of Tumor suppressor gene.
Allan Balmain mostly deals with Cancer research, Carcinogenesis, Genetics, Gene and Molecular biology. His research in Cancer research intersects with topics in Cancer, Mutation, Allele, Tumor suppressor gene and HRAS. His studies deal with areas such as Computational biology, Bioinformatics and Carcinogen as well as Cancer.
Allan Balmain has researched Allele in several fields, including Wild type, Genotype and Locus. Allan Balmain usually deals with Carcinogenesis and limits it to topics linked to Metastasis and Somatic evolution in cancer. His work in Molecular biology tackles topics such as Cell culture which are related to areas like Mutant.
His primary scientific interests are in Cancer research, Carcinogenesis, Genetics, Cancer and Gene. His biological study spans a wide range of topics, including Germline, KRAS, HRAS and Breast cancer, Estrogen receptor. His study in HRAS is interdisciplinary in nature, drawing from both Squamous carcinoma and Metastasis.
Carcinogenesis is a subfield of Internal medicine that Allan Balmain studies. The various areas that Allan Balmain examines in his Cancer study include Stem cell and Carcinogen. His work carried out in the field of Allele brings together such families of science as Germline mutation, Genome-wide association study, Genome instability, Molecular biology and Locus.
Cancer research, KRAS, HRAS, Carcinogenesis and Mutation are his primary areas of study. His Cancer research research is multidisciplinary, incorporating elements of Epithelial–mesenchymal transition, Cancer, Wnt signaling pathway, Germline and Stem cell. As a part of the same scientific family, Allan Balmain mostly works in the field of KRAS, focusing on Molecular biology and, on occasion, Proto-Oncogene Proteins p21, DNA, Cell aging, Chemical biology and Apoptosis.
Allan Balmain has included themes like Metastasis and Neuroblastoma RAS viral oncogene homolog in his HRAS study. Carcinogenesis is frequently linked to Mutant in his study. His Mutation research is classified as research in Gene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
TGF-beta signaling in tumor suppression and cancer progression.
Rik Derynck;Rosemary J. Akhurst;Allan Balmain.
Nature Genetics (2001)
Guidelines for the welfare and use of animals in cancer research
P Workman;E O Aboagye;F Balkwill;A Balmain.
British Journal of Cancer (2010)
Carcinogen-specific mutation and amplification of Ha- ras during mouse skin carcinogenesis
Miguel Quintanilla;Ken Brown;Martin Ramsden;Allan Balmain.
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno;Michelangelo Cordenonsi;Marco Montagner;Sirio Dupont.
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
Wei Cui;Deborah J Fowlis;Sheila Bryson;Elizabeth Duffie.
The genetics and genomics of cancer
Allan Balmain;Joe Gray;Bruce Ponder.
Nature Genetics (2003)
The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.
Anita J. Merritt;Christopher S. Potten;Christopher J. Kemp;John A. Hickman.
Cancer Research (1994)
Activation of the mouse cellular Harvey- ras gene in chemically induced benign skin papillomas
Allan Balmain;Martin Ramsden;George T. Bowden;John Smith.
How many mutations are required for tumorigenesis? implications from human cancer data
Allan Balmain;J. Carl Barrett;Harold Moses;Michael J. Renan.
Molecular Carcinogenesis (1993)
Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene.
Allan Balmain;Ian B. Pragnell.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: